Dr. Eleftherios Mylonakis, MD
Claim this profileHouston Methodist Hospital
Affiliated Hospitals
Houston Methodist Hospital
Rhode Island Hospital
Clinical Trials Eleftherios Mylonakis, MD is currently running
Sleep Treatments
for Long COVID Syndrome
The platform protocol is designed to be flexible so that it is suitable for a range of study settings and intervention types. Therefore, the platform protocol provides a general protocol structure that can be shared by multiple interventions and allows comparative analysis across the interventions. For example, objectives, measures, and endpoints are generalized in the platform protocol, but intervention-specific features are detailed in separate appendices. This platform protocol is a prospective, multi-center, multi-arm, randomized controlled platform trial evaluating potential interventions for PASC-mediated sleep disturbances. The hypothesis is that symptoms of sleep and circadian disorders that emerge in patients with PASC can be improved by phenotype-targeted interventions. Specific sleep and circadian disorders addressed in this protocol include sleep-related daytime impairment (referred to as hypersomnia) and complex PASC-related sleep disturbance (reflecting symptoms of insomnia and sleep-wake rhythm disturbance).
Recruiting
0 awards
Phase 2
1 criteria
Extracellular Vesicle Treatment
for Acute Respiratory Distress Syndrome
This trial tests a new treatment where tiny particles from bone marrow cells are used to help patients with severe lung problems by reducing inflammation and repairing lung damage.
Recruiting
1 award
Phase 3
2 criteria
More about Eleftherios Mylonakis, MD
Clinical Trial Related
1 year of experience running clinical trials · Led 5 trials as a Principal Investigator · 2 Active Clinical Trials
Treatments Eleftherios Mylonakis, MD has experience with
- AP-SA02
- Paxlovid
- Placebo
- Echinocandin
- Fluconazole
- Ibrexafungerp
Breakdown of trials Eleftherios Mylonakis, MD has run
Post-COVID Syndrome
Long COVID Syndrome
Staph Bacteremia
Bacterial Blood Infection
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Eleftherios Mylonakis, MD specialize in?
Eleftherios Mylonakis, MD focuses on Post-COVID Syndrome and COVID-19. In particular, much of their work with Post-COVID Syndrome has involved treating patients, or patients who are undergoing treatment.
Is Eleftherios Mylonakis, MD currently recruiting for clinical trials?
Yes, Eleftherios Mylonakis, MD is currently recruiting for 2 clinical trials in Houston Texas. If you're interested in participating, you should apply.
Are there any treatments that Eleftherios Mylonakis, MD has studied deeply?
Yes, Eleftherios Mylonakis, MD has studied treatments such as AP-SA02, Paxlovid, Placebo.
What is the best way to schedule an appointment with Eleftherios Mylonakis, MD?
Apply for one of the trials that Eleftherios Mylonakis, MD is conducting.
What is the office address of Eleftherios Mylonakis, MD?
The office of Eleftherios Mylonakis, MD is located at: Houston Methodist Hospital, Houston, Texas 77030 United States. This is the address for their practice at the Houston Methodist Hospital.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.